Gsa Capital Partners LLP Dare Bioscience, Inc. Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.94 - $1.76 $87,987 - $164,743	-93,604 Reduced 74.32%	32,350 $40,000
Q1 2022 May 11, 2022	SELL	$1.42 - $2.09 $22,562 - $33,208	-15,889 Reduced 11.2%	125,954 $188,000
Q4 2021 Feb 14, 2022	BUY	$1.42 - $2.13 $184,311 - $276,467	129,797 Added 1077.51%	141,843 $284,000
Q3 2021 Nov 12, 2021	BUY	$1.42 - $2.0 $17,105 - $24,092	12,046 New	12,046 $20,000
Q1 2021 May 10, 2021	SELL	$1.31 - $3.0 $189,063 - $432,969	-144,323 Closed	0 $0

Q4 2020 Feb 03, 2021	BUY	$0.96 - $1.51 $138,550 - $217,927	144,323 New	144,323 $193,000

6.86M

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $28.8M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.